Inverness gives Biosite revised commitment letter

NEW YORK, April 18 (Reuters) - Biosite Inc. BSTE.O said on Wednesday that Inverness Medical Innovations Inc. IMA.A has provided revised commitment letters from financing sources tied to Inverness' proposal to buy Biosite for $90.00 per share.

Biosite said its board would review the information provided by Inverness.

Biosite said last week it was prepared to enter into talks with Inverness, which it said ultimately could top an offer from Beckman Coulter Inc. (BEC.N).

((Reporting by Lewis Krauskopf, editing by Gerald E. McCormick; Reuters Messaging: Lewis.Krauskopf.reuters.com@reuters.net; lewis.krauskopf@reuters.com; 646-223-6082)) Keywords: BIOSITE INVERNESS/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEN6592